Zura Bio Limited Stock Analysis
ZURA Stock | 4.38 0.23 5.54% |
Zura Bio Limited is undervalued with Real Value of 7.29 and Target Price of 16.6. The main objective of Zura Bio stock analysis is to determine its intrinsic value, which is an estimate of what Zura Bio Limited is worth, separate from its market price. There are two main types of Zura Bio's stock analysis: fundamental analysis and technical analysis.
The Zura Bio stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Zura Bio's ongoing operational relationships across important fundamental and technical indicators.
Zura |
Zura Stock Analysis Notes
About 33.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 1.69. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Zura Bio Limited had not issued any dividends in recent years. For more information please call the company at 702-757-6133 or visit https://zurabio.com.Zura Bio Limited Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Zura Bio's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Zura Bio Limited or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Zura Bio Limited had very high historical volatility over the last 90 days | |
Net Loss for the year was (60.56 M) with profit before overhead, payroll, taxes, and interest of 0. | |
Zura Bio generates negative cash flow from operations | |
Zura Bio Limited has a poor financial position based on the latest SEC disclosures | |
About 33.0% of the company outstanding shares are owned by insiders | |
Latest headline from news.google.com: Zura Bio Limited Sees Large Increase in Short Interest - MarketBeat |
Zura Bio Limited Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Zura Bio previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
26th of March 2024 Upcoming Quarterly Report | View | |
10th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
26th of March 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Zura Largest EPS Surprises
Earnings surprises can significantly impact Zura Bio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2024-08-13 | 2024-06-30 | -0.15 | -0.17 | -0.02 | 13 | ||
2024-03-28 | 2023-12-31 | -0.23 | -0.19 | 0.04 | 17 | ||
2023-11-13 | 2023-09-30 | -0.25 | -0.18 | 0.07 | 28 |
Zura Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 264.66 M.Zura Profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.60) | (0.57) | |
Return On Capital Employed | (0.78) | (0.74) | |
Return On Assets | (0.60) | (0.57) | |
Return On Equity | (1.02) | (0.97) |
Management Efficiency
Zura Bio Limited has return on total asset (ROA) of (0.1699) % which means that it has lost $0.1699 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2644) %, meaning that it created substantial loss on money invested by shareholders. Zura Bio's management efficiency ratios could be used to measure how well Zura Bio manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.57. The current year's Return On Capital Employed is expected to grow to -0.74. At present, Zura Bio's Other Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 105.9 M, whereas Total Assets are forecasted to decline to about 90.6 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | 2.41 | 2.67 | |
Tangible Book Value Per Share | 2.41 | 2.67 | |
Enterprise Value Over EBITDA | (0.70) | (0.74) | |
Price Book Value Ratio | 2.42 | 2.30 | |
Enterprise Value Multiple | (0.70) | (0.74) | |
Price Fair Value | 2.42 | 2.30 | |
Enterprise Value | 39.6 M | 35.2 M |
The analysis of Zura Bio's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Zura Bio's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Zura Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta 0.153 | Return On Assets (0.17) | Return On Equity (0.26) |
Technical Drivers
As of the 5th of October, Zura Bio maintains the Market Risk Adjusted Performance of 0.4617, downside deviation of 4.01, and Mean Deviation of 3.38. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Zura Bio Limited, as well as the relationship between them.Zura Bio Limited Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Zura Bio middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Zura Bio Limited. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Zura Bio Limited Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Zura Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Zura Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Zura Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Zura Bio Outstanding Bonds
Zura Bio issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Zura Bio Limited uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Zura bonds can be classified according to their maturity, which is the date when Zura Bio Limited has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Boeing Co 2196 Corp BondUS097023DG73 | View | |
HSBC Holdings PLC Corp BondUS404280DR76 | View | |
AerCap Global Aviation Corp BondUS00773HAA59 | View |
Zura Bio Predictive Daily Indicators
Zura Bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Zura Bio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Zura Bio Corporate Filings
13A | 23rd of September 2024 An amended filing to the original Schedule 13G | ViewVerify |
16th of September 2024 Other Reports | ViewVerify | |
F4 | 13th of September 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
11th of September 2024 Other Reports | ViewVerify | |
9th of September 2024 Other Reports | ViewVerify | |
6th of September 2024 Other Reports | ViewVerify | |
5th of September 2024 Other Reports | ViewVerify | |
8K | 3rd of September 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Zura Bio Forecast Models
Zura Bio's time-series forecasting models are one of many Zura Bio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Zura Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Zura Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Zura Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Zura shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Zura Bio. By using and applying Zura Stock analysis, traders can create a robust methodology for identifying Zura entry and exit points for their positions.
Last Reported | Projected for Next Year |
Current Zura Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Zura analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Zura analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
16.6 | Strong Buy | 7 | Odds |
Most Zura analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Zura stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Zura Bio Limited, talking to its executives and customers, or listening to Zura conference calls.
Zura Stock Analysis Indicators
Zura Bio Limited stock analysis indicators help investors evaluate how Zura Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Zura Bio shares will generate the highest return on investment. By understating and applying Zura Bio stock analysis, traders can identify Zura Bio position entry and exit signals to maximize returns.
Begin Period Cash Flow | 1.6 M | |
Common Stock Shares Outstanding | 33.1 M | |
Total Stockholder Equity | 59.3 M | |
Cash And Short Term Investments | 99.8 M | |
Cash | 99.8 M | |
Accounts Payable | 2.7 M | |
Net Debt | -99.8 M | |
50 Day M A | 3.786 | |
Total Current Liabilities | 20.3 M | |
Other Operating Expenses | 62.6 M | |
Stock Based Compensation | 9.7 M |
Complementary Tools for Zura Stock analysis
When running Zura Bio's price analysis, check to measure Zura Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zura Bio is operating at the current time. Most of Zura Bio's value examination focuses on studying past and present price action to predict the probability of Zura Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zura Bio's price. Additionally, you may evaluate how the addition of Zura Bio to your portfolios can decrease your overall portfolio volatility.
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |